Concomitant drugs: Necessity, side-effects and interactions in the perioperative period;Begleitmedikation: Notwendigkeit, nebenwirkungen und interaktionen in der perioperativen phase

Anaesthesist

Volumn 48, Issue 4, 1999, Pages 267-283

  Roth, A ^a   Angster, R ^a   Forst, H ^a   Bardenheuer, H J ^b   Rossaint, R ^b   Spahn, D ^b  

^a Klinik fur Anasthesiologie und Operative Intensivmedizin   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPIVACAINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CLINDAMYCIN; CYTOCHROME P450; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LITHIUM; MAGNESIUM; METFORMIN; MONOAMINE OXIDASE INHIBITOR; NEUROMUSCULAR BLOCKING AGENT; NIFEDIPINE; NITRATE; TIMOLOL; UNINDEXED DRUG; VERAPAMIL;

ANESTHESIA; ANTIARRHYTHMIC ACTIVITY; ANTICONVULSANT THERAPY; ANTIHYPERTENSIVE THERAPY; ANTIVIRAL ACTIVITY; BRONCHODILATATION; COMBINATION CHEMOTHERAPY; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; MULTIPLE ORGAN FAILURE; NEUROMUSCULAR BLOCKING; PERIOPERATIVE PERIOD; REVIEW; VASODILATATION;

ANESTHESIA; DRUG INTERACTIONS; DRUG THERAPY; HUMANS; INTRAOPERATIVE PERIOD; PHARMACEUTICAL PREPARATIONS;

EID: 0032900583     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050701     Document Type: Review

References (29)

1. Bowdle TA (1998) Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Safety 19:173-189
2. Chang GWM, Kam PCA (1999) The physiological roles of cytochrome P450 isoenzymes. Anaesthesia 54:42-50
3. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277:301-306
4. Dale O, Olkkola KT (1998) Cytochrome P450, molecular biology and anaesthesia. Acta Anaesthesiol Scand 42:1025-1027
5. Dawson J, Karalliedde L (1998) Drug interaction and the clinical anaesthetist. Eur J Anaesthesiol 15:172-189
6. Doak GJ (1997) Discontinuing drugs before surgery. Can J Anaesth 44:R112-R117
7. Duthie DJ, Montgomery JN, Spence AA, Nimmo WS (1987) Concurrent drug therapy in patients undergoing surgery. Anaesthesia 42:305-6
8. Feldman S, Karalliedde L (1996) Drug interactions with neuromuscular blockers. Drug Safety 15:261- 273
9. Gogarten W, Van Aken H, Wulf H, Klose R, Vandermeulen E, Harenberg J (1997) Rückenmarksnahe Regionalanästhesie und Thromboembolieprophylaxe/Antikoagulation. Anaesth Intensivmed 38:623- 628
10. Hernandez Conte AT (1998) Human immunodeficiency virus therapy and potential anesthetic interactions. Semin Anaesth Periop Med Pain 17:299-307
11. Kam PCA, Chang GWM (1997) Selective serotonin reuptake inhibitors. Pharmacology and clinical implications in anaesthesia and critical care. Anaesthesia 52:982-988
12. Koslowski B, Heit W (1998) Kardiale Probleme des Tumorpatienten. Intensiv- und Notfallbehandlung 23:54-72
13. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 279:1200-1205
14. Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713-1720
15. Roots I, Brockmöller J (1996) Pharmakogenetik. In: Rietbrock N, Staib AH, Loew D (Hrsg) Klinische Pharmakologie, 3. Aufl. Steinkopf, Darmstadt, S. 101-120
16. Roerig DL, Kotryl KJ, Ahlf SB, Dawson CA, Kampine JP (1989) Effect of propranolol on the first pass uptake of fentanyl in the human and rat lung. Anesthesiology 71:62-68
17. Rundshagen I (1996) Perioperatives Management des Patienten mit atypischem Morbus Parkinson. AINS 31:49-52
18. Schirmer U (1998) Lachgas. Entwicklung und heutiger Stellenwert. Anaesthesist 47:245-255
19. Smith MS, Muir H, Hall R (1996) Perioperative management of drug therapy. Clinical considerations. Drugs 51:238-259
20. Souter AJ, Fredman B, White PF (1994) Controversies in the perioperative use of nonsteroidal anti- inflammatory drugs. Anaesth Analg 79:1178-1190
21. Stühmeier KD, Mainzer B, Cierpka J, Sandmann W, Tarnow J (1996) Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology 85:706-12
22. Teasdale S, Downar E (1990) Amiodarone and anaesthesia. Can J Anaesth 37:151-155
23. Trissel LA (1994) Handbook on injectable drugs, 10th edn. American Society of Hospital Pharmacists. Bethesda, MD
24. Tryba M, Horlocker TT, Wedel DJ (1999) Rückenmarksnahe Anästhesie und Antikoagulation. Ergebnisse einer Konsensuskonferenz der American Society of Regional Anesthesia (ASRA). Anaesth Intensivmed 40:88-92
25. Quist Christensen L, Bonde J, Kampmann JP (1994) Drug interactions with intravenous and local anaesthetics. Acta Anaesthesiol Scand 38:15-29
26. Ulsamer B (1988) Vecuroniumbromid: Beeinflussung der Pharmokodynamik durch Etomidat, Cimetidin und Ranitidin. Anaesthesist 37:504-509
27. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT (1998) Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88:7-17
28. Wood M (1991) Pharmacokinetic drug interactions in anaesthetic practice. Clin Pharmacokinet 21:285-307
29. Wyld R, Nimmo WS (1988) Do patients fasting before and after operation receive their prescribed drug treatment? Br Med J 296:744